Cargando…

The impact of standardized structured reporting of pathology reports for breast cancer care

PURPOSE: With the increasing complexity of modern oncological patient management and the growing amount of information needed from the pathologist, traditional narrative pathology reports (NR) do not suffice. Standardized synoptic reporting (SR) increases both completeness and readability. In the Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Snoek, J.A.A., Nagtegaal, I.D., Siesling, S., van den Broek, E., van Slooten, H.J., Hugen, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619179/
https://www.ncbi.nlm.nih.gov/pubmed/36308925
http://dx.doi.org/10.1016/j.breast.2022.10.011
_version_ 1784821220162666496
author Snoek, J.A.A.
Nagtegaal, I.D.
Siesling, S.
van den Broek, E.
van Slooten, H.J.
Hugen, N.
author_facet Snoek, J.A.A.
Nagtegaal, I.D.
Siesling, S.
van den Broek, E.
van Slooten, H.J.
Hugen, N.
author_sort Snoek, J.A.A.
collection PubMed
description PURPOSE: With the increasing complexity of modern oncological patient management and the growing amount of information needed from the pathologist, traditional narrative pathology reports (NR) do not suffice. Standardized synoptic reporting (SR) increases both completeness and readability. In the Netherlands SR for breast cancer was introduced in 2009. We explore the impact of synoptic reporting on breast cancer care. METHODS: Using data from the Netherlands Cancer Registry and Dutch Nationwide Pathology Databank, a retrospective population-based cohort study was performed. Data of breast cancer resections from 2007 to 2014 were collected to compare NR and SR for all outcome measures. Kaplan-Meier analyses and log-rank testing were used to estimate overall survival. RESULTS: Over time there was an increase from 12% to 78.9% in the use of SR. SR resulted in higher completeness of pathology reports, particularly for hormone and HER2/neu receptor status. Although there was no difference in the administration of antihormonal therapy, anti-HER2 treatment was more frequently administered to eligible patients in the SR group. An effect on overall survival could not yet be confirmed on multivariate analysis. CONCLUSIONS: We demonstrate that SR has led to more complete pathology reports, which meets the needs for precision of information in breast cancer care. This is expected to improve communication and discussions between specialists regarding parameters important for adjuvant breast cancer treatment decisions. SR thereby improves breast cancer care and leads to improved allocation of treatment based on pathologic parameters and more personalized treatment regimens.
format Online
Article
Text
id pubmed-9619179
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96191792022-11-01 The impact of standardized structured reporting of pathology reports for breast cancer care Snoek, J.A.A. Nagtegaal, I.D. Siesling, S. van den Broek, E. van Slooten, H.J. Hugen, N. Breast Original Article PURPOSE: With the increasing complexity of modern oncological patient management and the growing amount of information needed from the pathologist, traditional narrative pathology reports (NR) do not suffice. Standardized synoptic reporting (SR) increases both completeness and readability. In the Netherlands SR for breast cancer was introduced in 2009. We explore the impact of synoptic reporting on breast cancer care. METHODS: Using data from the Netherlands Cancer Registry and Dutch Nationwide Pathology Databank, a retrospective population-based cohort study was performed. Data of breast cancer resections from 2007 to 2014 were collected to compare NR and SR for all outcome measures. Kaplan-Meier analyses and log-rank testing were used to estimate overall survival. RESULTS: Over time there was an increase from 12% to 78.9% in the use of SR. SR resulted in higher completeness of pathology reports, particularly for hormone and HER2/neu receptor status. Although there was no difference in the administration of antihormonal therapy, anti-HER2 treatment was more frequently administered to eligible patients in the SR group. An effect on overall survival could not yet be confirmed on multivariate analysis. CONCLUSIONS: We demonstrate that SR has led to more complete pathology reports, which meets the needs for precision of information in breast cancer care. This is expected to improve communication and discussions between specialists regarding parameters important for adjuvant breast cancer treatment decisions. SR thereby improves breast cancer care and leads to improved allocation of treatment based on pathologic parameters and more personalized treatment regimens. Elsevier 2022-10-21 /pmc/articles/PMC9619179/ /pubmed/36308925 http://dx.doi.org/10.1016/j.breast.2022.10.011 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Snoek, J.A.A.
Nagtegaal, I.D.
Siesling, S.
van den Broek, E.
van Slooten, H.J.
Hugen, N.
The impact of standardized structured reporting of pathology reports for breast cancer care
title The impact of standardized structured reporting of pathology reports for breast cancer care
title_full The impact of standardized structured reporting of pathology reports for breast cancer care
title_fullStr The impact of standardized structured reporting of pathology reports for breast cancer care
title_full_unstemmed The impact of standardized structured reporting of pathology reports for breast cancer care
title_short The impact of standardized structured reporting of pathology reports for breast cancer care
title_sort impact of standardized structured reporting of pathology reports for breast cancer care
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619179/
https://www.ncbi.nlm.nih.gov/pubmed/36308925
http://dx.doi.org/10.1016/j.breast.2022.10.011
work_keys_str_mv AT snoekjaa theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT nagtegaalid theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT sieslings theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT vandenbroeke theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT vanslootenhj theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT hugenn theimpactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT snoekjaa impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT nagtegaalid impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT sieslings impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT vandenbroeke impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT vanslootenhj impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare
AT hugenn impactofstandardizedstructuredreportingofpathologyreportsforbreastcancercare